HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. (Q37658727)
Jump to navigation
Jump to search
scientific article published on 08 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. |
scientific article published on 08 October 2012 |
Statements
1 reference
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. (English)
1 reference
Chloe Orkin
1 reference
Silvia Montoto
1 reference
Kate Shaw
1 reference
Shreyans Gandhi
1 reference
Paul Fields
1 reference
Andrew Wilson
1 reference
Milensu Shanyinde
1 reference
Kate Cwynarski
1 reference
Robert Marcus
1 reference
Johannes de Vos
1 reference
Anna Marie Young
1 reference
Melinda Tenant-Flowers
1 reference
Margaret Johnson
1 reference
Daniella Chilton
1 reference
John G Gribben
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference